 Eric Pietras
Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 30 | 2023 | 338 | 8.480 |
Why?
| | Hematopoiesis | 13 | 2023 | 170 | 3.380 |
Why?
| | Bone Marrow | 9 | 2023 | 243 | 1.780 |
Why?
| | Dioxygenases | 3 | 2022 | 25 | 1.670 |
Why?
| | Inflammation | 12 | 2023 | 2464 | 1.470 |
Why?
| | Stress, Physiological | 3 | 2021 | 379 | 1.230 |
Why?
| | Proto-Oncogene Proteins | 5 | 2022 | 607 | 1.180 |
Why?
| | Cell Proliferation | 9 | 2021 | 2173 | 1.110 |
Why?
| | Interferon Type I | 5 | 2014 | 128 | 1.070 |
Why?
| | Leukemia | 4 | 2022 | 208 | 1.050 |
Why?
| | Mice | 37 | 2023 | 14843 | 1.030 |
Why?
| | Cell Cycle | 5 | 2021 | 541 | 1.020 |
Why?
| | Trans-Activators | 3 | 2022 | 366 | 0.950 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2023 | 13 | 0.840 |
Why?
| | Cell Differentiation | 11 | 2023 | 1696 | 0.810 |
Why?
| | Leukemia, Myeloid | 1 | 2022 | 40 | 0.810 |
Why?
| | Signal Transduction | 15 | 2023 | 4501 | 0.790 |
Why?
| | Neoplastic Stem Cells | 4 | 2020 | 327 | 0.780 |
Why?
| | Animals | 47 | 2023 | 31565 | 0.780 |
Why?
| | Multipotent Stem Cells | 3 | 2021 | 17 | 0.780 |
Why?
| | Cell Lineage | 4 | 2021 | 308 | 0.770 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2022 | 1128 | 0.700 |
Why?
| | Endothelial Protein C Receptor | 1 | 2019 | 5 | 0.680 |
Why?
| | Interleukin-1 | 4 | 2023 | 965 | 0.680 |
Why?
| | Flow Cytometry | 5 | 2021 | 1075 | 0.680 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 154 | 0.670 |
Why?
| | Antigens, CD34 | 1 | 2019 | 88 | 0.670 |
Why?
| | Hematologic Diseases | 2 | 2023 | 55 | 0.670 |
Why?
| | DNA-Binding Proteins | 4 | 2022 | 1311 | 0.630 |
Why?
| | Stem Cell Factor | 1 | 2018 | 14 | 0.610 |
Why?
| | Leukemia, Myeloid, Acute | 2 | 2023 | 533 | 0.600 |
Why?
| | Arthritis, Experimental | 1 | 2019 | 130 | 0.570 |
Why?
| | Health | 1 | 2017 | 74 | 0.560 |
Why?
| | Disease | 1 | 2017 | 85 | 0.540 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 381 | 0.510 |
Why?
| | Immunity, Innate | 6 | 2023 | 720 | 0.510 |
Why?
| | Myelodysplastic Syndromes | 3 | 2023 | 119 | 0.500 |
Why?
| | Virus Diseases | 2 | 2008 | 195 | 0.480 |
Why?
| | Cytokines | 7 | 2020 | 1824 | 0.470 |
Why?
| | Mice, Inbred C57BL | 13 | 2021 | 4680 | 0.470 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 519 | 0.470 |
Why?
| | Monocytes | 2 | 2022 | 503 | 0.470 |
Why?
| | HMGA2 Protein | 1 | 2013 | 8 | 0.440 |
Why?
| | Inflammation Mediators | 2 | 2020 | 475 | 0.410 |
Why?
| | Stem Cell Niche | 5 | 2023 | 41 | 0.380 |
Why?
| | Proto-Oncogene Proteins c-ets | 2 | 2022 | 51 | 0.370 |
Why?
| | Francisella tularensis | 1 | 2011 | 19 | 0.370 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2011 | 90 | 0.370 |
Why?
| | Receptors, CCR2 | 1 | 2011 | 28 | 0.370 |
Why?
| | Receptors, Interferon | 1 | 2011 | 47 | 0.360 |
Why?
| | Neoplasms | 3 | 2022 | 2086 | 0.360 |
Why?
| | Arthritis, Rheumatoid | 1 | 2019 | 1002 | 0.360 |
Why?
| | Phosphoproteins | 3 | 2020 | 293 | 0.360 |
Why?
| | Germ-Line Mutation | 2 | 2022 | 131 | 0.360 |
Why?
| | DNA | 1 | 2017 | 1350 | 0.350 |
Why?
| | Gene Expression | 5 | 2021 | 1417 | 0.340 |
Why?
| | Host-Pathogen Interactions | 2 | 2021 | 295 | 0.340 |
Why?
| | RNA Splicing Factors | 2 | 2020 | 49 | 0.330 |
Why?
| | Aging | 5 | 2021 | 1611 | 0.320 |
Why?
| | Cell Cycle Proteins | 2 | 2011 | 549 | 0.310 |
Why?
| | TNF Receptor-Associated Death Domain Protein | 1 | 2008 | 2 | 0.310 |
Why?
| | Viruses | 2 | 2008 | 94 | 0.300 |
Why?
| | Stem Cells | 3 | 2022 | 541 | 0.300 |
Why?
| | Mitochondria | 4 | 2020 | 744 | 0.300 |
Why?
| | Mice, Transgenic | 5 | 2023 | 1947 | 0.290 |
Why?
| | Homeostasis | 2 | 2021 | 570 | 0.290 |
Why?
| | Mutation | 7 | 2023 | 3338 | 0.290 |
Why?
| | Immunity | 1 | 2008 | 121 | 0.280 |
Why?
| | MicroRNAs | 1 | 2013 | 600 | 0.280 |
Why?
| | Reactive Oxygen Species | 2 | 2020 | 522 | 0.280 |
Why?
| | Mitochondrial Proteins | 2 | 2008 | 213 | 0.280 |
Why?
| | Humans | 33 | 2023 | 114045 | 0.270 |
Why?
| | Regeneration | 2 | 2020 | 158 | 0.260 |
Why?
| | Interleukin-1beta | 3 | 2021 | 368 | 0.260 |
Why?
| | Diet, Western | 2 | 2023 | 66 | 0.250 |
Why?
| | Bacterial Infections | 1 | 2006 | 217 | 0.220 |
Why?
| | B-Lymphocytes | 3 | 2022 | 762 | 0.220 |
Why?
| | Splicing Factor U2AF | 2 | 2023 | 16 | 0.210 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2022 | 140 | 0.210 |
Why?
| | Interferon Regulatory Factors | 2 | 2020 | 31 | 0.210 |
Why?
| | fas Receptor | 4 | 2008 | 91 | 0.200 |
Why?
| | Spliceosomes | 2 | 2020 | 38 | 0.200 |
Why?
| | Myeloid Cells | 2 | 2021 | 126 | 0.200 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 2022 | 81 | 0.200 |
Why?
| | Cholinergic Agents | 1 | 2022 | 15 | 0.200 |
Why?
| | Disease Models, Animal | 3 | 2020 | 3498 | 0.190 |
Why?
| | Up-Regulation | 3 | 2021 | 802 | 0.190 |
Why?
| | Receptors, Notch | 2 | 2020 | 83 | 0.190 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2021 | 34 | 0.190 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2022 | 307 | 0.190 |
Why?
| | Carcinogenesis | 1 | 2022 | 175 | 0.180 |
Why?
| | DNA Damage | 2 | 2021 | 351 | 0.180 |
Why?
| | Repressor Proteins | 2 | 2022 | 367 | 0.180 |
Why?
| | Myelopoiesis | 2 | 2018 | 6 | 0.180 |
Why?
| | Clone Cells | 1 | 2021 | 247 | 0.180 |
Why?
| | Nuclear Receptor Co-Repressor 2 | 1 | 2020 | 14 | 0.180 |
Why?
| | Bone Marrow Diseases | 1 | 2020 | 18 | 0.180 |
Why?
| | Melanoma, Experimental | 1 | 2021 | 89 | 0.170 |
Why?
| | Staphylococcus aureus | 3 | 2010 | 385 | 0.170 |
Why?
| | Drug Therapy | 1 | 2020 | 74 | 0.170 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2021 | 56 | 0.170 |
Why?
| | Apoptosis | 5 | 2014 | 2349 | 0.170 |
Why?
| | Cellular Reprogramming | 3 | 2017 | 84 | 0.170 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2021 | 144 | 0.170 |
Why?
| | Bacteria | 1 | 2006 | 725 | 0.170 |
Why?
| | Mice, Knockout | 5 | 2021 | 2562 | 0.170 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 256 | 0.160 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2019 | 18 | 0.160 |
Why?
| | Histone Deacetylases | 1 | 2020 | 194 | 0.160 |
Why?
| | Darkness | 1 | 2018 | 23 | 0.160 |
Why?
| | Thrombocytopenia | 1 | 2020 | 177 | 0.160 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 146 | 0.150 |
Why?
| | Interferon Inducers | 1 | 2018 | 7 | 0.150 |
Why?
| | Cells, Cultured | 5 | 2021 | 3861 | 0.150 |
Why?
| | Staphylococcal Skin Infections | 2 | 2010 | 29 | 0.150 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 385 | 0.150 |
Why?
| | Models, Biological | 3 | 2015 | 1611 | 0.150 |
Why?
| | Poly I-C | 1 | 2018 | 51 | 0.150 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 445 | 0.140 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2020 | 636 | 0.140 |
Why?
| | Granulocyte-Macrophage Progenitor Cells | 1 | 2017 | 4 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2019 | 328 | 0.140 |
Why?
| | Neutrophils | 4 | 2023 | 1089 | 0.140 |
Why?
| | Antineoplastic Agents | 4 | 2020 | 1875 | 0.140 |
Why?
| | Cell Self Renewal | 1 | 2017 | 49 | 0.140 |
Why?
| | Heart Diseases | 1 | 2020 | 329 | 0.130 |
Why?
| | Neutrophil Infiltration | 2 | 2007 | 94 | 0.130 |
Why?
| | Intervertebral Disc | 1 | 2017 | 36 | 0.130 |
Why?
| | Blood Platelets | 1 | 2019 | 326 | 0.130 |
Why?
| | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 4 | 0.130 |
Why?
| | Thrombosis | 1 | 2019 | 295 | 0.130 |
Why?
| | RNA Splicing | 3 | 2023 | 244 | 0.120 |
Why?
| | Lymphoid Progenitor Cells | 1 | 2015 | 11 | 0.120 |
Why?
| | Myeloid Progenitor Cells | 1 | 2015 | 15 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2016 | 237 | 0.120 |
Why?
| | Cell Division | 1 | 2016 | 754 | 0.110 |
Why?
| | Mice, Congenic | 1 | 2014 | 21 | 0.110 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2014 | 15 | 0.110 |
Why?
| | Cell Cycle Checkpoints | 1 | 2014 | 84 | 0.110 |
Why?
| | Primary Myelofibrosis | 1 | 2013 | 9 | 0.110 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2006 | 367 | 0.110 |
Why?
| | Myeloproliferative Disorders | 1 | 2013 | 26 | 0.110 |
Why?
| | Cellular Senescence | 1 | 2014 | 151 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2018 | 677 | 0.110 |
Why?
| | DNA Replication | 1 | 2014 | 202 | 0.100 |
Why?
| | Cell Survival | 2 | 2014 | 1014 | 0.100 |
Why?
| | TNF Receptor-Associated Factor 3 | 3 | 2007 | 5 | 0.100 |
Why?
| | Transcription Factors | 2 | 2018 | 1526 | 0.100 |
Why?
| | Tularemia | 1 | 2011 | 16 | 0.090 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 94 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2011 | 213 | 0.090 |
Why?
| | Chemokine CCL2 | 1 | 2011 | 104 | 0.090 |
Why?
| | Liver | 1 | 2018 | 1633 | 0.090 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 344 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 445 | 0.090 |
Why?
| | Megakaryocytes | 2 | 2020 | 29 | 0.090 |
Why?
| | Interleukin-17 | 1 | 2010 | 104 | 0.080 |
Why?
| | Gene Deletion | 1 | 2011 | 356 | 0.080 |
Why?
| | Spleen | 1 | 2011 | 485 | 0.080 |
Why?
| | Cell Line | 5 | 2021 | 2629 | 0.080 |
Why?
| | Receptors, Interleukin-1 | 2 | 2007 | 228 | 0.080 |
Why?
| | RNA Viruses | 1 | 2008 | 28 | 0.080 |
Why?
| | Skin | 2 | 2010 | 653 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2011 | 673 | 0.070 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2007 | 17 | 0.070 |
Why?
| | Dinucleoside Phosphates | 1 | 2007 | 24 | 0.070 |
Why?
| | Biomarkers | 1 | 2018 | 3397 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 140 | 0.070 |
Why?
| | Endopeptidases | 1 | 2007 | 70 | 0.070 |
Why?
| | Caspases | 2 | 2005 | 243 | 0.070 |
Why?
| | RNA, Double-Stranded | 1 | 2006 | 44 | 0.070 |
Why?
| | Antibody Formation | 1 | 2007 | 266 | 0.070 |
Why?
| | Male | 8 | 2021 | 55396 | 0.060 |
Why?
| | Lipopolysaccharides | 2 | 2019 | 813 | 0.060 |
Why?
| | Membrane Glycoproteins | 2 | 2005 | 429 | 0.060 |
Why?
| | Toll-Like Receptors | 1 | 2006 | 167 | 0.060 |
Why?
| | Listeria monocytogenes | 1 | 2006 | 111 | 0.060 |
Why?
| | Female | 7 | 2023 | 59324 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2007 | 340 | 0.050 |
Why?
| | Bone Marrow Cells | 3 | 2011 | 266 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 2004 | 438 | 0.050 |
Why?
| | RNA, Viral | 1 | 2006 | 565 | 0.050 |
Why?
| | Chemotaxis | 1 | 2023 | 128 | 0.050 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 518 | 0.050 |
Why?
| | Thrombopoiesis | 1 | 2022 | 6 | 0.050 |
Why?
| | Macaca mulatta | 1 | 2022 | 131 | 0.050 |
Why?
| | Primates | 1 | 2023 | 110 | 0.050 |
Why?
| | Apoptosis Regulatory Proteins | 3 | 2008 | 170 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 57 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2020 | 1518 | 0.050 |
Why?
| | Mice, SCID | 1 | 2022 | 312 | 0.050 |
Why?
| | Macrophages | 2 | 2020 | 1259 | 0.050 |
Why?
| | Time-Lapse Imaging | 1 | 2021 | 19 | 0.050 |
Why?
| | Leukemia, Myelomonocytic, Acute | 1 | 2021 | 7 | 0.050 |
Why?
| | Candidiasis | 1 | 2021 | 51 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 552 | 0.050 |
Why?
| | Cell Movement | 1 | 2004 | 863 | 0.040 |
Why?
| | Microscopy, Fluorescence | 1 | 2021 | 393 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 224 | 0.040 |
Why?
| | Adoptive Transfer | 1 | 2020 | 194 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 924 | 0.040 |
Why?
| | Antigens, CD | 1 | 2021 | 440 | 0.040 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2019 | 25 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 65 | 0.040 |
Why?
| | Cohort Studies | 2 | 2020 | 4883 | 0.040 |
Why?
| | RAW 264.7 Cells | 1 | 2019 | 41 | 0.040 |
Why?
| | K562 Cells | 1 | 2019 | 73 | 0.040 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 76 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 590 | 0.040 |
Why?
| | Protein Transport | 1 | 2020 | 391 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2019 | 98 | 0.040 |
Why?
| | Fluorouracil | 1 | 2019 | 152 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 24 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 77 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2021 | 337 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2019 | 337 | 0.040 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2019 | 270 | 0.040 |
Why?
| | NF-kappa B | 3 | 2007 | 636 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2018 | 1735 | 0.040 |
Why?
| | Granulocytes | 1 | 2017 | 75 | 0.030 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 271 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2017 | 50 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 686 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 743 | 0.030 |
Why?
| | Interferon-alpha | 2 | 2007 | 185 | 0.030 |
Why?
| | beta Catenin | 1 | 2017 | 218 | 0.030 |
Why?
| | Osteogenesis | 1 | 2017 | 181 | 0.030 |
Why?
| | Caspase 8 | 2 | 2005 | 43 | 0.030 |
Why?
| | Minichromosome Maintenance Proteins | 1 | 2014 | 3 | 0.030 |
Why?
| | Fas Ligand Protein | 2 | 2005 | 57 | 0.030 |
Why?
| | Down-Regulation | 1 | 2017 | 594 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2014 | 79 | 0.030 |
Why?
| | Thrombopoietin | 1 | 2013 | 4 | 0.030 |
Why?
| | Chemokine CCL3 | 1 | 2013 | 15 | 0.030 |
Why?
| | Cell Transdifferentiation | 1 | 2013 | 31 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 1888 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2090 | 0.020 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2011 | 34 | 0.020 |
Why?
| | Feedback, Physiological | 1 | 2011 | 68 | 0.020 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2011 | 60 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 2784 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 5499 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2013 | 445 | 0.020 |
Why?
| | Histones | 1 | 2014 | 529 | 0.020 |
Why?
| | Hematologic Neoplasms | 1 | 2011 | 136 | 0.020 |
Why?
| | Risk Factors | 1 | 2022 | 8614 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2008 | 128 | 0.020 |
Why?
| | Interleukins | 1 | 2010 | 236 | 0.020 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2007 | 17 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2007 | 26 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 211 | 0.020 |
Why?
| | Ubiquitin | 1 | 2007 | 57 | 0.020 |
Why?
| | Ubiquitination | 1 | 2007 | 86 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2007 | 55 | 0.020 |
Why?
| | Neutrophil Activation | 1 | 2007 | 78 | 0.020 |
Why?
| | STAT1 Transcription Factor | 1 | 2007 | 63 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2007 | 197 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 448 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2007 | 145 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 4402 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2010 | 719 | 0.020 |
Why?
| | Sendai virus | 1 | 2006 | 15 | 0.020 |
Why?
| | Intracellular Fluid | 1 | 2006 | 27 | 0.020 |
Why?
| | DNA Primers | 1 | 2007 | 508 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 388 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2007 | 534 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2014 | 2322 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 796 | 0.020 |
Why?
| | Death Domain Receptor Signaling Adaptor Proteins | 1 | 2005 | 2 | 0.020 |
Why?
| | Toll-Like Receptor 2 | 1 | 2006 | 110 | 0.020 |
Why?
| | Cycloheximide | 1 | 2005 | 53 | 0.020 |
Why?
| | Dactinomycin | 1 | 2005 | 25 | 0.020 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2005 | 23 | 0.020 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 2005 | 45 | 0.010 |
Why?
| | Chemokines | 1 | 2006 | 215 | 0.010 |
Why?
| | Caspase Inhibitors | 1 | 2005 | 77 | 0.010 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2004 | 28 | 0.010 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 40 | 0.010 |
Why?
| | Mice, Inbred C3H | 1 | 2005 | 242 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2007 | 435 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 1981 | 0.010 |
Why?
| | Phosphorylation | 1 | 2007 | 1558 | 0.010 |
Why?
| | Oligopeptides | 1 | 2005 | 234 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2005 | 771 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2783 | 0.010 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2003 | 181 | 0.010 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 271 | 0.010 |
Why?
| | Alleles | 1 | 2005 | 789 | 0.010 |
Why?
| | Child | 1 | 2020 | 18401 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 2700 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 26605 | 0.010 |
Why?
|
|
Pietras's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|